In light of the ongoing threat posed by new viruses following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the COVID-19 pandemic, new antiviral drugs ...
JENA, Germany, Nov. 15, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced ...
Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...
In a recent article published in the JAMA Internal Medicine Journal, researchers from Missouri in the United States (US) performed an observational cohort study using the US Department of Veterans ...
Viragen is soaring more than 133 percent to 28 cents on tremendous volume of 46.6 million shares. The avalanche of interest in the penny stock comes in response to news that the Plantation, Fla., ...
Chinese scientists announced Thursday that, together with colleagues from the United States and France, they have completed the whole genome sequencing of a bacterium that causes people to suffer ...
As efforts build to find an effective treatment for severe acute respiratory syndrome, doctors gather at the National Institutes of Health in Washington, D.C. Researchers familiar with the struggle to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results